Atlas Trials

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Clinical trial NCT07346235 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07346235
Sponsor
American Hospital 2 Kosovo
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Infertility, Female
Start date
2026-03-01
Primary completion
2028-01-01
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.